Adding Talazoparib to Enzalutamide Prolongs Imaging-Based PFS in Metastatic Androgen Pathway Modulation-Sensitive Prostate Cancer with Alterations in HRR Genes By Ogkologos - June 15, 2026 54 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TALAPRO-3 study Source RELATED ARTICLESMORE FROM AUTHOR Treatment with Encorafenib Plus Cetuximab Plus FOLFIRI Improves Outcomes in Patients with BRAF V600E-mutated mCRC FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors MOST POPULAR Check Out An All New GreaterGood.Com And Our Renewed Commitment To... September 30, 2019 Interpreted cancer awareness workshops: talking about cancer with South-Asian communities October 4, 2022 Data Collection Analysis Demonstrates Changes in Lung Cancer Management Throughout the... March 26, 2021 Cancer Clinical Trials Bounce Back After Significant COVID-19 Disruption: Data From... June 15, 2022 Load more HOT NEWS Significant PFS Benefit in Patients with HR-positive, HER2-negative MBC Who Switched... Study Shows Supplements Increase Risk of Relapse and Death in Breast... EMA Recommends Extension of Therapeutic Indications for Asciminib ΣΑΡΚΩΜΑ
